WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: #WBA) INVESTOR ALERT: Investors With Large Losses in Walgreen Boots Alliance, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights #securitiesfraud https://lnkd.in/ejbXF563
Bernstein Liebhard LLP’s Post
More Relevant Posts
-
Walgreens Boots Alliance Inc (WBA US) Ranked Negative On January 19th, 2024 Nancy Schlicting (Director since 2006) sold 15,209 shares on January 16th at $23.05, reducing her stock holdings to zero. In addition, she does own 71,251 DSUs so still has meaningful ownership. Her last sale was of a similar size in November 2022 at $40, which proved timely and was the reason for our downgrade at the time. This sale, while similar in size, is at a lower price point but also somewhat concerning in that the company just named a new CEO, Timothy Wentworth, just three months ago in Oct. 2023. He did make a recent purchase, spending $242,000, which slightly offsets this sale from Schlicting. Nevertheless, Schlicting’s sale, into weakness and soon after a new CEO takes over, is not encouraging. Schlicting was the former CEO of Henry Ford Health Systems from 2003-2016. We are ranking the stock -N. Learn more: https://lnkd.in/emeEcwde #USstockmarket #smartinsider #insidertrading #equities #alternativedata #trading #investing #investment #insiderdeals #insidertransaction #stockmarket #stockmarkets #investmentmanagement #portfoliomanagement #portfoliomanager #investmentstrategy #altdata
To view or add a comment, sign in
-
This evolving landscape reflects the dynamic nature of the retail industry. ALDI's acquisition, Southeastern Grocers' divestment, and the partnerships with CVS and Walgreens all contribute to a vibrant and interconnected marketplace. For a comprehensive insight into these transformative shifts and their broader significance, explore this latest article. Your feedback and thoughts are welcome! #retail #grocery #executivesearch #groceryindustry #newsarticle
To view or add a comment, sign in
-
📉 Walgreens Boots Alliance (WBA) Stock Drops 20% Amid Profit Guidance Cuts This morning, Walgreens Boots Alliance (WBA) saw a dramatic 20% drop in stock value after announcing a significant reduction in its profit guidance — the second downward adjustment this year. 📊 Revised Earnings Guidance: New Estimate: $2.80 - $2.95 per share Previous Estimate: $3.20 - $3.35 per share 🔍 CEO Tim Wentworth's New Strategy: CEO Tim Wentworth is executing a new strategy focused on revitalizing pharmacies and scaling back on healthcare services through VillageMD, where Walgreens is no longer a major stakeholder. 💼 Operational Changes: Downsizing unprofitable business segments Announcing additional store closures Tackling pricing pressures from prescription drugs 💬 Key Quote from CEO Tim Wentworth: "We're at the point where the current pharmacy model is not sustainable and the challenges in our operating environment require we approach the market differently. We are in active discussions ... to align incentives and ensure we are paid fairly." 📉 Impact of Pharmacy Benefits Managers (PBMs): PBMs are squeezing profit margins by setting prescription prices. Popular branded drugs (e.g., Mounjaro, Zepbound, Ozempic, Wegovy) offer lower profits. Ongoing shortages are reducing the supply of higher-margin generic drugs. 🏪 Store Performance and Shrink: 100% of profits come from 75% of stores, but the number of store closures is still undecided. Inflation is impacting discretionary spending, leading to a shift towards preferred partner brands and Walgreens' in-house brand. 📉 Current Stock Performance: Price: $11.73 (-25.13%) As of: 12:31 PM EDT Investors and industry watchers are closely monitoring these changes as Walgreens navigates a challenging market environment. #Walgreens #WBA #StockMarket #BusinessStrategy #Pharmacy #Earnings #Retail #Healthcare
To view or add a comment, sign in
-
-
Walgreens Boots Alliance Inc (NASDAQ:WBA) has reported first-quarter sales that beat expectations, sending its #shares higher in Thursday premarket trading. The company, which is reported to be exploring a spinoff of its UK-based Boots UK drugstore chain, posted a 10% increase in sales to $36.7 billion for the three months to November 30, 2023, above the $34.9 billlion expected by analysts polled by Zacks Investment Research. Adjusted earnings per share (EPS) fell 43% to $0.66, in line with consensus expectations. It attributed the decline to challenging retail market trends in the US and a 21 percentage point headwind from a higher tax rate. It cuts its quarterly dividend by 48% to $0.25 per share. "WBA delivered fiscal first quarter results in line with overall expectations, reflecting disciplined execution in a challenging consumer backdrop,” CEO Tim Wentworth commented in a statement. More at #Proactive #ProactiveInvestors #NASDAQ #WBA #WalgreensBootsAlliance #Walgreens #Boots http://ow.ly/im1L1057PtA
Walgreens shares rise on 1Q sales beat
proactiveinvestors.com
To view or add a comment, sign in
-
After owner Walgreens Boots Alliance (WBA) decided not to pursue a £5 billion sale or stock market flotation of the company for the second time in two years, Boots CEO Sebastian James plans to step down in November. WBA will continue a strategic review of Boots' assets despite the company's strong recent trading performance, with like-for-like sales rising 5.8% in pharmacy and 6% in retail. The proprietor is still dedicated to making investments in Boots UK and coming up with creative ideas to help the company reach its full potential. Amid worries about the state of the world economy and difficulties in finding a suitable replacement for Boots' £8 billion pension plan, the failed sale plan attracted only one formal offer worth roughly £5.5 billion. Following his appointment as Boots' CEO in 2018, Sebastian James has agreed to take on a new position in the health care world. With roughly 1900 locations across the UK, Boots employs about 52,000 people. #TalkSocialToUs #Boots #WalgreensBootsAlliance #BusinessLeadership #StrategicReview #UKEconomy #TheSocialTalks
To view or add a comment, sign in
-
-
🔴 Breaking News 🔴 Boots chief, Elizabeth Fagan, is set to step down as the sale process of the popular high street retailer stalls, as reported by the Financial Times. Fagan's departure comes at a critical juncture for Boots, known for its wide-ranging health and beauty products, as the company navigates a challenging retail landscape. The decision underscores the dynamic nature of the retail industry and the need for agile leadership in times of change. What are your thoughts on this development? Share your insights in the comments below. #Boots #RetailIndustry #LeadershipChange https://ift.tt/Pn8Mj4k
🔴 Breaking News 🔴 Boots chief, Elizabeth Fagan, is set to step down as the sale process of the popular high street retailer stalls, as reported by the Financial Times. Fagan's departure comes at a critical juncture for Boots, known for its wide-ranging health and beauty products, as the company navigates a challenging retail landscape. The decision underscores the dynamic nature of the ...
ft.com
To view or add a comment, sign in
-
Rosalind Brewer is stepping down as chief executive officer of Walgreens Boots Alliance effective immediately amid the drugstore giant’s flagging share price and a multibillion transformation to provide more healthcare services. Will these changes affect Walgreens’ retail locations? Huge transformations can often include closure of underperforming locations to shore up the books. If you are a buyer or seller of retail net lease assets, this is the kind of information you need to stay ahead of the investment market. NNNTrends.com is a resource where you can find up-to-the-minute national and regional cap rates, consumer traffic, and comparable sales for dozens of national net lease tenants! #Walgreens #CRE #commercialrealestate #realestatenews #pharmacy #healthcare
To view or add a comment, sign in
-
-
Ultimately: as Mega Group Health Plan Sponsors work directly with Large Healthcare Systems in their Employee/Patient Access Area, Walgreens Boots Alliance may have to align with Elevance Health inorder to compete with the other 3 BUCAs ( OptumRx/UHC; ExpressScripts/Cigna, CVS/Aetna) for ASO Business under AdvancedPCP Model favored by Employer Coalitions/Business Health Care Groups for the mid2020s. Interesting to see how Morgan Health/AffirmedRx will be included in the developing Self-insured Competition.
Ouch! In late 2021, Walgreens invested $5.2 billion in VillageMD, increasing its ownership stake in the company from 30% to 63%.
Walgreens plans to close some 60 VillageMd clinics
chainstoreage.com
To view or add a comment, sign in
-
Please find an interesting blog post below 👇, Recommended by Total Books Accountants, Bookkeepers & Tax advisers. More speculation about possible Boots sell-off Boots UK owner Walgreens Boots Alliance (WBA) is looking at listing the pharmacy and beauty retailer on the London Stock Exchange after an absence of 16 years, according to Bloomberg. The report suggests that WBA and Boots are considering an initial public offering (IPO), which would value the UK company in the region of £7bn, returning it to the FTSE 100. Alliance Boots was previously listed before its acquisition by private equity firm KKR in 2007. An attempt to offload the company last year failed. Neither Boots UK nor WBA would comment on the Bloomberg report. In July Boots announced it was closing 300 branches, while last month WBA agreed a £4.8bn deal with Legal and General (L&G) to take over responsibility for the Boots pension scheme. Boots UK’s pharmacy sales rose by 9.9 percent in the year to August 31. https://bit.ly/3SMZkyv
Rumours about possible Boots sell-off circulate again
pharmacymagazine.co.uk
To view or add a comment, sign in
-
Accountants & Tax Advisors . ✔We promise numbers that make sense ✔ Giving you Peace of Mind | Cardiff & Bristol
Please find an interesting blog post below 👇, Recommended by Total Books Accountants, Bookkeepers & Tax advisers. More speculation about possible Boots sell-off Boots UK owner Walgreens Boots Alliance (WBA) is looking at listing the pharmacy and beauty retailer on the London Stock Exchange after an absence of 16 years, according to Bloomberg. The report suggests that WBA and Boots are considering an initial public offering (IPO), which would value the UK company in the region of £7bn, returning it to the FTSE 100. Alliance Boots was previously listed before its acquisition by private equity firm KKR in 2007. An attempt to offload the company last year failed. Neither Boots UK nor WBA would comment on the Bloomberg report. In July Boots announced it was closing 300 branches, while last month WBA agreed a £4.8bn deal with Legal and General (L&G) to take over responsibility for the Boots pension scheme. Boots UK’s pharmacy sales rose by 9.9 percent in the year to August 31. https://bit.ly/3SMZkyv
Rumours about possible Boots sell-off circulate again
pharmacymagazine.co.uk
To view or add a comment, sign in